First-ever undergraduate competitor takes the gold for project to develop a universal labeling system for hazardous drugs.

Multimillion-dollar initiative will help bring safe biopharmaceutical products to market faster and develop workforce training programs for the biopharmaceutical field.

Researchers from academia, government, and industry examine both established and emerging techniques to detect protein aggregation in biologic drug products.

Dr. Richard Dalby steps down as associate dean for academic affairs; former chair of the Department of Pharmaceutical Sciences named as successor.

Presentations delivered by leaders across academia and industry highlight new methods and approaches to drug design that attendees can apply in their laboratories.

More than 200 PharmD and graduate students receive degrees and embark on the next phase of their lives.

Fellowships will provide students with the hands-on experience and leadership skills needed to pursue careers in clinical drug development.

Research Day offers an opportunity for students and trainees to showcase their current research and network with potential collaborators.

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.

More than 100 faculty, staff, students, alumni, and guests gather in Pharmacy Hall to kick-off the School’s anniversary with a grand birthday celebration.

Fourth annual M-CERSI “America’s Got Regulatory Science Talent” competition awards third-year student pharmacists first prize for novel solution to improve FDA’s post-marketing surveillance program.